ReviewCurrent atherosclerosis reports2025
Dietary Management of Atherogenic Dyslipidemia.
Review in Current atherosclerosis reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction and validation of a machine learning-based model for predicting pneumonia risk in patients with hemorrhagic stroke.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
purpose of reviewThis paper reviews the effects of major macronutrients and specific dietary interventions on atherogenic dyslipidemia, a common trait characterized by increased concentrations of triglyceride-rich and small, dense LDL particles, and reduced HDL-cholesterol. RECENT
findingsStudies have shown that reducing carbohydrate intake is the most effective dietary approach for managing atherogenic dyslipidemia, particularly in individuals with excess adiposity and/or metabolic syndrome. Plant protein sources can also be beneficial, possibly due to their content of phytochemicals. Whereas dietary guidelines emphasize limiting intake of saturated fat for reducing cardiovascular risk by lowering concentrations of LDL cholesterol, this has not been shown to have an impact on atherogenic dyslipidemia. Attenuation or reversal of atherogenic dyslipidemia can be achieved by adopting a dietary pattern that emphasizes moderating carbohydrate intake, in particular processed grains and added sugars, rather than by focusing primarily on limiting saturated fat and its effects on LDL-cholesterol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.